The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Both companies have been selected for stand-by production by German government
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products
The new unit will be built with INEOS’ latest process technology and aims to substantially improve the sustainability of our supply to our customers and reduce our environmental impact
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai
Subscribe To Our Newsletter & Stay Updated
